The Long Read: Kent IVF Cuts Leave Women Facing a Fertility Postcode Lottery

NHS Kent and Medway has cut funded IVF from two cycles to one, lowered the age rule from under 40 to treatment before a woman’s 38th birthday, and left the public without the full human arithmetic. For some women in Kent, this won’t be a policy change. It’ll be the end of the road.

For women across Kent and Medway, this isn’t a small-print NHS adjustment. It’s a decision about time, biology, money, loss and hope. From 1 April 2026, NHS Kent and Medway Integrated Care Board, the local NHS body responsible for commissioning health services, reduced its funded fertility offer. The previous local offer was treatment under 40, up to two IVF or ICSI cycles, and up to four embryo transfers. The new offer is treatment before the woman’s 38th birthday, one IVF or ICSI cycle, and up to two embryo transfers. That is the cut. Everything else is explanation.

The responsibility sits with NHS Kent and Medway ICB. Its own public page says it has “agreed to make changes” to the current fertility policy to align Kent and Medway with most other areas, focus resources where clinical success rates are highest, and protect long-term service sustainability. Its formal ART policy says Kent and Medway ICB is the NHS organisation responsible for “commissioning health services for the local population”, and that ICBs have a “statutory duty to maintain financial balance”. That is the money frame. The human consequence is that Kent women now have fewer NHS-funded chances than they had before.

The policy trail also shows this was a formal ICB decision, not a clerical tidy-up. The ART policy’s own document history records that the April 2026 changes to “the number of IVF cycles funded and the upper age criterion” were agreed by the Kent and Medway ICB EMT Strategic Commissioning Subgroup on 24 February 2026. In other words, the local NHS body responsible for commissioning services signed off the reduction before it came into force on 1 April 2026.

Kent County Council’s Health Overview and Scrutiny Committee — HOSC — did not make the cut. Its role is to scrutinise substantial NHS service changes affecting Kent residents. But the scrutiny chronology is troubling. KCC’s report says HOSC and Medway’s Health and Adult Social Care Overview and Scrutiny Committee had previously treated an Assisted Reproductive Technology review as a substantial variation of service in 2018, with scrutiny passed to the Kent and Medway NHS Joint Overview and Scrutiny Committee. Scrutiny was then suspended in 2020 when the former CCG said it wasn’t progressing the changes, but it was expected to resume when the review restarted.

Instead, the new policy came into effect first. The current KCC report says NHS Kent and Medway recognises HOSC “should have been formally consulted” before the changes were approved and implemented on 1 April 2026. The ICB’s own briefing goes further, saying HOSC should have “formally heard about the proposals” before implementation and apologising that this did not happen. In plain English, KCC HOSC was bypassed until after the ICB policy was already live, leaving it open to potential legal challenge.

The immediate hard number is this: NHS Kent and Medway says that, based on 2024/25 activity, around 60 women aged 38 to 40 would no longer be eligible each year because of the age cut. But that is only the first visible number. The same briefing says the reduction from two cycles to one “will affect a wider group”. It does not say how many. That missing number is not an administrative detail. It is the undisclosed count of people who would previously have had a second NHS-funded chance, and now won’t.

The new ART policy shows how tight the gate now is. It says funding is available only where women receiving fertility treatment are under 38, meaning they “must start medication with the ART provider before their 38th birthday”. It also says women must only be referred to fertility clinics if there is “adequate time to complete work up”. In other words, a woman approaching 38 isn’t just racing biology. She is racing GP referral, tests, clinic processing, prior approval and the start of medication.

The policy also makes clear that eligibility is not the same as treatment. It says patients are required to fulfil specified eligibility criteria to access NHS-funded ART, but “eligibility for NHS funding is not the same as a guarantee of treatment”. That is an important line. A woman can fit the policy on paper and still find that the clinical decision, timing, prior approval, ovarian reserve or other criteria leave her without treatment in practice.

The other criteria are far from incidental. Women receiving treatment must have a BMI between 19 and 30. The partner providing sperm must have a BMI below 30. Treatment won’t be funded if the woman undergoing treatment smokes tobacco, or if the partner providing sperm smokes tobacco, though people using e-cigarettes are not excluded on that basis. Couples are excluded if either partner has a living child or ongoing viable pregnancy from the current or a previous relationship; single people are excluded if they have a living child. Women must also have an AMH level of more than 5.4 pmol/l, a marker used in assessing ovarian reserve.

There is a particularly sharp line buried in the IVF eligibility section. To demonstrate subfertility, patients may qualify if they have not conceived after two years of regular unprotected sexual intercourse, but a footnote states: “if there have been any miscarriages during this 2 year period, patients will not be eligible for NHS ART.” That sentence needs testing carefully by HOSC, because to a lay reader it appears to mean that pregnancy loss during the evidential period can stop a patient qualifying through that route. For women who have already endured miscarriage, that is not a small clause. It is a policy line landing on top of grief.

The actual funded IVF offer is now tightly capped. The policy says eligible couples or individuals requiring IVF, with or without ICSI, will be funded for a maximum of two embryo transfer procedures, of which no more than one can be a fresh cycle. It also says once egg collection has commenced, the cycle counts as complete and will count as the NHS-funded cycle. So if the first cycle does not lead to a baby, the NHS-funded route may already be exhausted unless there is a funded frozen transfer within the cap.

Embryo storage is also limited. The policy says storage of cryopreserved supernumerary embryos after IVF will be funded for a maximum of two years following the fresh IVF cycle, ending sooner if the patient has a live birth or exceeds ICB eligibility criteria. After that, patients may self-fund continued cryopreservation and future frozen embryo transfer. That is another quiet shift from public funding to private means.

The policy says there is “no blanket ban” on the treatments covered, because clinicians can make an Individual Funding Request if a patient does not meet the criteria or if the treatment is not routinely funded. But that route is limited to patients thought to meet criteria for “exceptionality” or “rarity”. That is not the same as routine access. It is an exceptions door, not a replacement for the main entrance that has just been narrowed.

The private-care section adds another sting. The policy says the NHS should “never subsidise private care with public money”, patients should not be charged for NHS care or allowed to pay towards an NHS service, and patients should not be able to mix different elements of the same treatment between NHS and private care. That may protect core NHS principles, but for patients it also means a hard separation. Once the NHS-funded chance is gone, buying extra pieces of the same pathway is not straightforward; the patient is pushed into a private market with private prices.

The private-care cliff is steep. HFEA, the UK fertility regulator, says whether someone can have IVF on the NHS depends on where they live, because funding decisions are made locally. It also says one cycle of private IVF costs about £5,000 on average, although this varies considerably, with possible extra costs for embryo storage and initial appointments. In Kent, that means losing NHS funding can quickly become a bill running into thousands of pounds before a second attempt is even considered.

Local prices show the point in pounds. Care Fertility Tunbridge Wells advertises a pre-treatment bundle at £575, IVF using own eggs from £4,950, and a multi-cycle package from £9,550. It also advertises a Care Value IVF package at £3,500 including medication, but with a fertility assessment required separately. TFP Simply Fertility’s Kent page lists a fertility assessment at £590, screening blood tests at £600, single-cycle IVF at £6,485, single-cycle IVF plus ICSI at £7,940, and medication from £300 to £3,250.

That is why this cut is also an inequality story. A wealthier woman may be able to buy back the second chance the NHS has removed. A poorer woman cannot. A couple with savings, family support, credit options or property may try again. A renter, a low-paid worker, a single woman, a disabled woman, a carer, or a couple already under pressure from Kent housing costs may have to stop. The ICB frames the cut as clinical prioritisation and sustainability. In practice, it risks becoming an income filter on hope.

The clinical context is not simple, and it should not be simplified. IVF success does decline with age. NHS Kent and Medway says the age change is aligned with clinical effectiveness and that after 37 “live births by embryo transfer reduce significantly year on year”. HFEA’s national data supports the importance of age, but it does not show that women aged 38 or 39 have no chance. In 2023, average pregnancy rates per fresh embryo transferred using patients’ own eggs were 41% for patients aged 18 to 34, 34% for 35 to 37, and 25% for 38 to 39.

That is the uncomfortable truth. The case is not that IVF at 39 is the same as IVF at 32. It isn’t. The case is that Kent and Medway has removed routine NHS access from a group where IVF can still work. HFEA’s 2023 report also says the average preliminary birth rate from fresh embryo transfers was 25% nationally, 35% for patients aged 18 to 34, and 5% for patients aged 43 to 44 using their own eggs. The 38 to 39 group sits between those figures, not outside the realm of treatment.

NICE’s new 2026 guidance makes the local cut look even starker. NICE says IVF should be offered to eligible women, trans men and non-binary people with female reproductive organs who have not reached their 42nd birthday if they meet the criteria. For those under 40, NICE says to offer an initial three full cycles of IVF. If they have not conceived after three full cycles, clinicians should discuss success probability and consider up to three further full cycles. For those aged 40 or 41 who meet the criteria and have not had IVF before, NICE says to offer one full cycle.

Kent and Medway now offers one cycle, and treatment must start before the 38th birthday. That is below NICE on both age and number of cycles. NHS Kent and Medway’s briefing acknowledges that NICE guidance is not mandatory and that local commissioners decide what can be funded within available resources. But the public should not miss the direction of travel. Kent and Medway has not moved closer to NICE. It has moved further away from it.

The broader fertility picture explains why this matters. NHS information says around one in seven couples may have difficulty conceiving. More than eight out of ten couples where the woman is under 40 conceive naturally within a year if they have regular unprotected sex every two or three days, but for couples who have been trying for more than three years without success, the chance of getting pregnant naturally within the next year is one in four or less. NHS causes include ovulation problems, damaged fallopian tubes, endometriosis, fibroids, pelvic inflammatory disease and male-factor infertility; in around one in four couples, a cause cannot be identified.

IVF itself is physically demanding. The NHS describes a full cycle as taking around three to six weeks, involving daily injections or nasal spray, further medication to increase egg supply, scans and tests, and egg collection using a needle inserted through the vagina, usually with sedation. HFEA also identifies risks including ovarian hyperstimulation syndrome, multiple pregnancy, ectopic pregnancy and procedure-related complications. This is not a lifestyle perk. It is invasive medical treatment.

The mental toll is just as real. HFEA says fertility treatment can be an “emotional rollercoaster”, and that clinics licensed by HFEA must offer the opportunity to talk to a counsellor before treatment. NHS Kent and Medway’s own engagement page says fertility treatment is “deeply personal and often emotional”, and the ICB briefing says feedback highlighted the need for better psychological support. A one-cycle policy loads more pressure onto one attempt, one egg collection, one embryo transfer pathway, one result. If it fails, grief and financial decision-making arrive together.

The public engagement base was thin. NHS Kent and Medway says it ran engagement between 26 November 2025 and 26 January 2026 through an online survey, social media, outreach to voluntary and community organisations and stakeholders, plus a separate survey for fertility services staff. Forty-nine members of the public and seven staff responded. For a county-wide change affecting fertility treatment across Kent and Medway, that is not exactly a democratic thunderclap.

Even that limited feedback did not cheer the cut. The briefing says feedback showed “strong support for maintaining current IVF provision, particularly two funded cycles”, plus concern about fairness, inequality, access and psychological support. NHS Kent and Medway says the change does not align with the public preference for two cycles, but responds to the call for national consistency because 69% of ICBs in England fund a single cycle. That wording is doing a lot of work. The public asked for fairness and support. The ICB delivered less treatment.

National data shows the postcode lottery is not imaginary. HFEA reported that in 2023, 52,400 patients had more than 77,500 IVF cycles in UK licensed fertility clinics, and that around 20,700 babies were born as a result of IVF. IVF accounted for about one in 32 UK births. But NHS-funded IVF has fallen: HFEA says the average proportion of NHS-funded IVF cycles in the UK dropped from 35% in 2019 to 27% in 2023, and in England it was 24%.

Government transparency data, published before the April 2026 Kent cut, recorded Kent and Medway as offering two non-full cycles for age up to 40, with no children from current or previous relationships, no more than two previous NHS or self-funded IVF cycles, and cryopreservation funded for a maximum of two years. That official snapshot is now out of date for Kent and Medway because the ICB has cut the offer. But it is useful because it shows the before-and-after: Kent has moved from the two-cycle column into the one-cycle world.

Older Kent and Medway papers show why HOSC should demand the current numbers. In 2017, when commissioners were considering a similar reduction, a Medway health scrutiny appendix said there were approximately 500 patients accessing NHS-funded ART services across Kent and Medway each year, and modelling suggested eligibility would reduce to about 215 if funded IVF cycles fell from two to one. It estimated approximately 285 patients would be affected by reducing the number of NHS-funded IVF cycles to one. That is not the current 2026 impact figure. But it proves commissioners can model the impact when they choose to.

The same 2017 material set out the clinical meaning of losing a second cycle. It said a reduction from two to one NHS-funded IVF cycle would reduce the likely chance of a birth from 49% to 32%, based on HFEA figures then cited for women under 40. Again, those are historic figures and should not be presented as current HFEA 2026 success rates. But they are relevant to scrutiny because they show the old system understood the obvious point: a second funded cycle was not decorative. It could materially improve the cumulative chance of a baby.

There is also an equality gap in the published material. NHS Kent and Medway says a full Equality, Health Inequalities and Quality Impact Assessment was completed, and that age was the main area of impact, while other protected characteristics such as race, disability and sexual orientation were not directly affected. But HFEA’s 2023 report says treatment outcomes vary by ethnicity, with average birth rates per embryo transferred in 2022–23 lower for Asian and Black patients aged 18 to 37 than for White patients. HOSC should therefore ask for the full EQHIA, not just the headline conclusion.

HFEA also reports changing family formation. Single patients increasingly used both IVF and donor insemination from 2019 to 2023, with IVF use among single patients up 83%. NICE’s 2026 guideline says it applies regardless of sexual orientation, partnership status or gender identity, where people meet the relevant criteria. Kent and Medway’s policy does include routes for single people, same-sex couples and people using donor sperm, but those patients must still navigate the local eligibility maze and the new tighter age and cycle limits.

So how many women are being deprived of treatment? The honest answer is: at least around 60 women a year aged 38 to 40 will lose eligibility because of the age cut, according to the ICB’s own briefing. A wider group will lose the second NHS-funded IVF or ICSI cycle, but the ICB has not put that number in the HOSC papers. Historic local modelling from 2017 suggested a two-to-one cycle reduction could affect hundreds of patients, but HOSC needs the 2026 equivalent before anyone can put a current figure on the full loss.

That missing data is the core democratic failure. The crucial missing data is the ICB’s current annual number of fertility approvals, first cycles, second cycles, embryo transfers, age profile, deprivation profile, ethnicity profile, complaints, and the estimated saving. Without that, the public has been given the headline cut but not the full human arithmetic. It knows the door has narrowed. It still does not know exactly how many people have been shut out.

HOSC should not simply note the report. It should require NHS Kent and Medway to publish the full engagement report, the full EQHIA, the decision record from the EMT Strategic Commissioning Subgroup, the clinical evidence, the financial modelling, the expected saving, the provider impact, the current activity data, and the forecast effect by age, district, deprivation, ethnicity, disability, sexuality and family type. It should also ask why a change previously treated as a substantial variation reached implementation before formal scrutiny heard it.

The final question is not complicated. How many Kent women will now be told that the NHS would have helped them last year, but will not help them this year? NHS Kent and Medway made the cut. HOSC was not formally consulted before implementation. The engagement feedback favoured maintaining two funded cycles. NICE recommends more than Kent and Medway now offers. Private treatment costs thousands. The physical and emotional burden sits with women and families, not with the committees that sign off the policy.

And that is where the policy language runs out. Because behind “financial balance”, “clinical effectiveness” and “sustainability” are women watching birthdays become deadlines, miscarriages become eligibility problems, and one failed funded attempt become a private invoice they may never be able to pay. Kent and Medway’s IVF cut is not just a commissioning decision. For some women, it is the moment the NHS says: your chance is over, unless you can afford another one.

Seen something the public should know about? Send tips, documents or concerns to TheShepwayVoxTeam(at)proton(dot)me. You can contact us in confidence, speak off the record in the first instance, and help us follow the evidence where it leads.

The Shepway Vox Team

Discernibly Different Dissent